NEOPLASMS, COLON
Clinical trials for NEOPLASMS, COLON explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, COLON trials appear
Sign up with your email to follow new studies for NEOPLASMS, COLON, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in colon cancer fight
Disease control Recruiting nowThis study tests whether adding the drug dostarlimab to standard chemotherapy (CAPEOX) works better than chemotherapy alone for a certain type of colon cancer. The treatment is given before surgery to shrink tumors. About 120 people with stage III or T4N0 colon cancer that has no…
Matched conditions: NEOPLASMS, COLON
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 26, 2026 04:29 UTC
-
Immunotherapy showdown: could dostarlimab replace chemo for some colon cancers?
Disease control Recruiting nowThis study tests whether the immunotherapy drug dostarlimab, given before and after surgery, works better than standard treatments for people with a specific type of colon cancer (dMMR/MSI-H) that has not spread. About 892 participants will be randomly assigned to receive either …
Matched conditions: NEOPLASMS, COLON
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 18, 2026 12:07 UTC